{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-059697","form_type":"8-K","ticker":"MDT","cik":"0001613103","company_name":"Medtronic plc","filed_at":"2026-09-01T10:47:19+00:00","discovered_at":"2026-09-01T10:50:00.422614+00:00","generated_at":"2026-09-01T10:50:04.123750+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Medtronic Q1 FY27 revenue up 13.7% to $9.76B; raises FY27 guidance","bullets":["Q1 revenue $9.756B, +13.7% reported and organic; GAAP EPS $1.14, non-GAAP EPS $1.45.","Raises FY27 organic revenue growth to 7.25-7.75% (from 6.75-7.25%) and non-GAAP EPS to $5.94-6.00.","Cardiovascular +18.9% organic, Neuroscience +9.3%, Medical Surgical +10.2%, Diabetes +14.9%.","Extra fiscal week added ~$570M to Q1 organic growth; completed acquisitions of Scientia Vascular and SPR Therapeutics.","Announced strategic investments in Pi-Cardia and Cornerstone Robotics; FDA clearance for Touch Surgery Aide."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-059697","json":"https://secwatch.observer/filing/0001628280-26-059697.json","markdown":"https://secwatch.observer/filing/0001628280-26-059697.md","text":"https://secwatch.observer/filing/0001628280-26-059697.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026059697/0001628280-26-059697-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026059697/mdt-20260901.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-01T10:50:04.123750+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}